Syra Health Corp. Class A Common StockSYRANASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +42.49% | +13.62% | +6.02% | -1.19% | -25.09% |
| Gross Profit Growth | +20.51% | -21.76% | +96.53% | +115.11% | -17.02% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +66.61% | +13.13% | +11.85% | +80.83% | +64.34% |
| Weighted Average Shares Diluted Growth | +66.61% | +13.13% | +11.85% | +80.83% | +64.34% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -15.11% | -42.51% | -3.11% | -10.46% | -3.26% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +69.75% | -25.27% | -18.21% | +7.20% | -26.26% |
| Book Value per Share Growth | +0.00% | -36.60% | -36.32% | -36.19% | -59.64% |
| Debt Growth | -69.41% | +82.21% | -0.79% | -76.61% | -58.93% |
| R&D Expense Growth | +0.00% | -102.13% | -86.61% | -89.31% | -97.66% |
| SG&A Expenses Growth | -67.43% | -27.43% | -29.93% | -46.00% | +170.72% |